The Lovesac Company Announces Participation in the 2024 ICR Conference
STAMFORD, Conn., Jan. 02, 2024 (GLOBE NEWSWIRE) — The Lovesac Company (Nasdaq: LOVE) (the “Company”) today announced that the Company […]
Nature’s Sunshine Announces Participation at the 26th Annual Needham Growth Conference on January 19, 2024
LEHI, Utah, Jan. 02, 2024 (GLOBE NEWSWIRE) — Nature’s Sunshine Products, Inc. (NASDAQ: NATR) (Nature’s Sunshine), a leading natural health […]
Ultragenyx to Present at the 42nd Annual J.P. Morgan Healthcare Conference
NOVATO, Calif., Jan. 02, 2024 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development […]
Windtree Therapeutics Announces Reduction In Arrythmias In A New Study With Istaroxime And A Pure SERCA2a Activator
The new preclinical data further supports istaroxime clinical data from three Phase 2 studies Arrythmias can be a serious complication of […]
Kirby Corporation Announces Date for 2023 Fourth Quarter Earnings Release and Earnings Webcast
HOUSTON, Jan. 02, 2024 (GLOBE NEWSWIRE) — Kirby Corporation (“Kirby”) (NYSE: KEX) will announce its 2023 fourth quarter results at […]
Olema Oncology to Present at 42nd Annual J.P. Morgan Healthcare Conference
SAN FRANCISCO, Jan. 02, 2024 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company […]
Kiniksa Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare Conference
HAMILTON, Bermuda, Jan. 02, 2024 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will present at […]
Nurix Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
SAN FRANCISCO, Jan. 02, 2024 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein […]
Bank OZK Announces Increase to Quarterly Common Stock Dividend and Announces Preferred Stock Dividend
LITTLE ROCK, Ark., Jan. 02, 2024 (GLOBE NEWSWIRE) — Bank OZK (the “Bank”) (Nasdaq: OZK) announced its Board of Directors […]
Cytokinetics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Jan. 02, 2024 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, […]
